Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

Prescription, Nonprescription and Orphan Drugs

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Drug Products: Biologics, Biosimilars and Interchangeables

Drug Products: Biologics, Biosimilars and Interchangeables

Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient Preferences for Public and Private Diabetes Care: A Discrete Choice Experiment Study in Vietnam.

Value in health regional issues·2026

Same author

Factors associated with changes in DALYs in five Asian health systems, 2000-2019.

Health policy (Amsterdam, Netherlands)·2026

Same author

Income-Based Inequalities in Health System Performance in the US and South Korea.

JAMA health forum·2026

Same author

Income-related disparities in the value of health care in South Korea.

Health affairs scholar·2025

Same author

Physicians Have an Ethical Duty to Practice Cost-Effective Medicine.

The American journal of bioethics : AJOB·2025

Same author

Dementia care in a rapidly aging society.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

Pharmaceutical policy in China.

Qiang Sun¹, Michael A Santoro, Qingyue Meng

¹Center for Health Management and Policy, Shandong University, in Jinan, People's Republic of China. karene@stanford.edu

Health Affairs (Project Hope)

|July 9, 2008

Summary

This summary is machine-generated.

China's pharmaceutical policies create conflicting objectives, hindering both industry growth and public health. This has led to increased costs, inappropriate prescribing, and issues with medicine availability and quality.

More Related Videos

Technical Approach for Structural Analysis of an Unknown Compound in Huoxiang Zhengqi Oral Liquid based on Linear Ion Trap Mass Spectrometry

Technical Approach for Structural Analysis of an Unknown Compound in Huoxiang Zhengqi Oral Liquid based on Linear Ion Trap Mass Spectrometry

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 3, 2026

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules

Published on: November 4, 2022

Technical Approach for Structural Analysis of an Unknown Compound in Huoxiang Zhengqi Oral Liquid based on Linear Ion Trap Mass Spectrometry

Technical Approach for Structural Analysis of an Unknown Compound in Huoxiang Zhengqi Oral Liquid based on Linear Ion Trap Mass Spectrometry

Published on: April 3, 2026

Area of Science:

Health Policy
Pharmaceutical Economics
Public Health

Background:

China's pharmaceutical policy faces challenges balancing domestic industry development with cost control.
Government aims to subsidize public hospitals via drug pricing while simultaneously capping expenses.
Price caps and profit-margin regulations are implemented to ensure patient access, particularly for low-income individuals.

Purpose of the Study:

To analyze the impact of China's dual-objective pharmaceutical policies.
To evaluate the consequences of these policies on market incentives, consumer costs, and prescribing practices.
To assess the overall effect on public health outcomes and medicine accessibility.

Main Methods:

Analysis of China's pharmaceutical pricing and regulation strategies.
Examination of the relationship between policy goals and market outcomes.
Assessment of pharmaceutical spending as a proportion of total health expenditure.

Main Results:

Policies have distorted market incentives and increased consumer costs.
Inappropriate prescribing practices are financially rewarded.
Pharmaceuticals constitute a significant portion of healthcare spending (approx. 50%), impacting inpatient and outpatient visits.
Essential medicines face availability and quality concerns.

Conclusions:

Contradictory pharmaceutical policies in China undermine public health.
The current system leads to economic inefficiencies and compromised patient care.
Urgent policy reform is needed to ensure both industry growth and equitable access to quality medicines.